These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3285822)

  • 1. Atherosclerotic vascular disease in middle-aged, insulin-treated, diabetic patients. Association with endogenous insulin secretion capacity.
    Rönnemaa T; Laakso M; Puukka P; Kallio V; Pyörälä K
    Arteriosclerosis; 1988; 8(3):237-44. PubMed ID: 3285822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atherosclerotic vascular disease and its risk factors in non-insulin-dependent diabetic and nondiabetic subjects in Finland.
    Laakso M; Rönnemaa T; Pyörälä K; Kallio V; Puukka P; Penttilä I
    Diabetes Care; 1988 Jun; 11(6):449-63. PubMed ID: 3402300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fasting plasma C-peptide, glucagon stimulated plasma C-peptide, and urinary C-peptide in relation to clinical type of diabetes.
    Gjessing HJ; Matzen LE; Faber OK; Frøland A
    Diabetologia; 1989 May; 32(5):305-11. PubMed ID: 2666217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic effect of islet B-cell function in insulin-treated diabetes.
    Gjessing HJ; Matzen LE; Iversen S; Faber OK; Frøland A
    Scand J Clin Lab Invest; 1989 Jun; 49(4):337-43. PubMed ID: 2662383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High fasting plasma insulin is an indicator of coronary heart disease in non-insulin-dependent diabetic patients and nondiabetic subjects.
    Rönnemaa T; Laakso M; Pyörälä K; Kallio V; Puukka P
    Arterioscler Thromb; 1991; 11(1):80-90. PubMed ID: 1988007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications.
    Scheen AJ; Castillo MJ; Lefèbvre PJ
    Diabetes Metab; 1996 Dec; 22(6):397-406. PubMed ID: 8985647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperinsulinaemia as a possible risk factor of macrovascular disease in diabetes mellitus. An overview.
    Janka HU; Standl E
    Diabete Metab; 1987 Jul; 13(3 Pt 2):279-83. PubMed ID: 3308556
    [No Abstract]   [Full Text] [Related]  

  • 8. Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients.
    Creutzfeldt WO; Kleine N; Willms B; Orskov C; Holst JJ; Nauck MA
    Diabetes Care; 1996 Jun; 19(6):580-6. PubMed ID: 8725855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of insulin deficiency among initially non-insulin-dependent middle-aged diabetic individuals.
    Laakso M; Sarlund H; Pyörälä K
    Diabetes Care; 1986; 9(3):228-31. PubMed ID: 3525053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-stimulated and postprandial plasma C-peptide values as measures of insulin secretory capacity.
    Koskinen PJ; Viikari JS; Irjala KM
    Diabetes Care; 1988 Apr; 11(4):318-22. PubMed ID: 3042307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual insulin secretion in individuals with type 1 diabetes in Finland: longitudinal and cross-sectional analyses.
    Harsunen M; Haukka J; Harjutsalo V; Mars N; Syreeni A; Härkönen T; Käräjämäki A; Ilonen J; Knip M; Sandholm N; Miettinen PJ; Groop PH; Tuomi T
    Lancet Diabetes Endocrinol; 2023 Jul; 11(7):465-473. PubMed ID: 37290465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between the serum level of C-peptide and risk factors for coronary heart disease and diabetic microangiopathy in patients with type-2 diabetes mellitus.
    Inukai T; Matsutomo R; Tayama K; Aso Y; Takemura Y
    Exp Clin Endocrinol Diabetes; 1999; 107(1):40-5. PubMed ID: 10077354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrovascular complications in relation to hyperinsulinaemia in non-insulin-dependent diabetes mellitus.
    Pyörälä K; Uusitupa M; Laakso M; Siitonen O; Niskanen L; Rönnemaa T
    Diabete Metab; 1987 Jul; 13(3 Pt 2):345-9. PubMed ID: 3308562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon-C-peptide test as a measure of insulin requirement in type 2 diabetes: evaluation of stopping insulin therapy in eleven patients.
    Viikari J; Rönnemaa T; Koskinen P
    Ann Clin Res; 1987; 19(3):178-82. PubMed ID: 3314647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects.
    Uusitupa MI; Niskanen LK; Siitonen O; Voutilainen E; Pyörälä K
    Circulation; 1990 Jul; 82(1):27-36. PubMed ID: 2194696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of octreotide on insulin requirement, hepatic glucose production, growth hormone, glucagon and c-peptide levels in type 2 diabetic patients with chronic renal failure or normal renal function.
    Di Mauro M; Papalia G; Le Moli R; Nativo B; Nicoletti F; Lunetta M
    Diabetes Res Clin Pract; 2001 Jan; 51(1):45-50. PubMed ID: 11137181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity and reproducibility of urinary C-peptide as estimate of islet B-cell function in insulin-treated diabetes.
    Gjessing HJ; Matzen LE; Faber OK; Frøland A
    Diabet Med; 1989; 6(4):329-33. PubMed ID: 2524338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Family history of Type 1 diabetes affects insulin secretion in patients with 'Type 2' diabetes.
    Lundgren VM; Andersen MK; Isomaa B; Tuomi T
    Diabet Med; 2013 May; 30(5):e163-9. PubMed ID: 23157220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-induced plasma C-peptide response in diabetic patients. Influence of body weight and relationship to insulin requirement.
    Scheen AJ; Castillo MJ; Lefèbvre PJ
    Diabetes Metab; 1996 Dec; 22(6):455-8. PubMed ID: 8985655
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma lipid abnormalities and risk factors for coronary artery disease in Japanese subjects with diabetes mellitus and glucose intolerance.
    Yamada N; Yoshinaga H; Gotoda T; Harada K; Shimada M; Ohsuga J; Akanuma Y; Murase T
    Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S215-20. PubMed ID: 7859608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.